The Montreal Health Innovations Coordinating Center (MHICC)赞助的临床试验
总计14个结果
-
Montreal Heart InstituteThe Montreal Health Innovations Coordinating Center (MHICC)完全的
-
DalCor PharmaceuticalsThe Montreal Health Innovations Coordinating Center (MHICC)招聘中
-
Inogen Inc.The Montreal Health Innovations Coordinating Center (MHICC)完全的
-
Montreal Heart InstituteThe Montreal Health Innovations Coordinating Center (MHICC); Ceapro Inc.招聘中
-
Louis BhererThe Montreal Health Innovations Coordinating Center (MHICC)招聘中
-
Montreal Heart InstituteMedtronic - MITG; The Montreal Health Innovations Coordinating Center (MHICC)完全的
-
Montreal Heart InstituteThe Montreal Health Innovations Coordinating Center (MHICC); Ceapro Inc.完全的
-
DalCor PharmaceuticalsCovance; The Montreal Health Innovations Coordinating Center (MHICC)完全的
-
Bio-K Plus International Inc.Montreal Heart Institute; The Montreal Health Innovations Coordinating Center (MHICC)未知
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR); The Montreal Health Innovations Coordinating...招聘中
-
Louis BhererCanadian Institutes of Health Research (CIHR); The Montreal Health Innovations Coordinating...招聘中
-
Milestone Pharmaceuticals Inc.The Montreal Health Innovations Coordinating Center (MHICC); JSS Medical Research Inc.完全的
-
DalCor PharmaceuticalsMedpace, Inc.; The Montreal Health Innovations Coordinating Center (MHICC); Roche Molecular Systems...完全的急性冠状动脉综合征瑞典, 美国, 巴西, 保加利亚, 法国, 意大利, 俄罗斯联邦, 南非, 西班牙, 火鸡, 英国, 德国, 匈牙利, 波兰, 罗马尼亚, 加拿大, 阿根廷, 澳大利亚, 奥地利, 比利时, 智利, 捷克语, 丹麦, 芬兰, 以色列, 荷兰, 新西兰, 葡萄牙, 波多黎各, 斯洛伐克, 瑞士, 阿拉伯联合酋长国
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR); The Montreal Health Innovations Coordinating... 和其他合作者终止